
Synthetic cell built from non-living parts completes multiple generations of growth and division
University of Minnesota researchers assemble a minimal cell that feeds, grows, and replicates, though it still depends on externally supplied ribosomes and has not been peer-reviewed.
A team at the University of Minnesota has constructed a synthetic cell from off-the-shelf chemical components that can feed, grow, copy its genetic instructions, and divide for five to ten generations. The work, described in a preprint not yet accepted by a peer-reviewed journal, marks the first time a cell built entirely from non-living molecules has completed multiple life-cycle rounds, including a form of selection in which a genetic modification that boosted growth allowed a variant to outcompete the original. The cell, named SpudCell, contains a defined genome of about 90,000 base pairs across seven DNA plasmids and a few hundred types of proteins and small molecules, making it far simpler than any natural organism.
The mechanism sidesteps a long-standing obstacle in synthetic biology. Natural cells divide using an internal cytoskeleton, a complex protein scaffold that has been difficult to engineer from scratch. SpudCell instead produces proteins that crowd the inner membrane surface until mechanical stress forces the compartment to split. The cell imports nutrients and uses ribosomes taken from E. coli to translate its genes, but it cannot yet manufacture its own ribosomes. Because those borrowed ribosomes degrade, each lineage dies out after five to ten generations. The genome is also fragmented, so genetic information is not reliably passed intact to daughter cells.
Viewed from the United States, the project is led by synthetic biologist Kate Adamala, who has launched a public-interest initiative called Biotic to standardise the platform and allow other laboratories to reproduce and extend the work. UK-based researchers not involved in the study, such as Yuval Elani of Imperial College London, described the result as a genuine advance in the long-running effort to organise chemistry into life-like behaviour. John Glass of the J. Craig Venter Institute, a leading centre for minimal-cell research, said the Minnesota cell is closer to being “alive” than any previous bottom-up construction. The team itself stops short of calling SpudCell a living organism, emphasising that it is an engineered approximation that reproduces core cellular behaviours while remaining dependent on external molecular machinery.
The next concrete milestone is the submission of the manuscript for formal peer review, which Adamala says is imminent. Beyond that, the Biotic consortium aims to consolidate the cell’s seven DNA molecules into a single stable genome and to engineer the capacity to build ribosomes internally, steps that would extend lineage persistence and reduce reliance on supplied components. The work does not yet constitute a living system, but it provides a controlled chassis for probing which genes and structures are truly essential for basic cellular tasks.
| Atlantic / Anglosphere press | +0.70 | aligned |
|---|---|---|
| Continental European press | −0.20 | neutral |
| Indian & South Asian press | 0.00 | neutral |
| Latin American press | −0.30 | critical |
Anglosphere science celebrates the triumph of biological engineering: SpudCell shows that life can be designed and replicated without the 'spark of life', a step toward a future of personalized medicine and sustainable production.
It emphasizes technical progress and practical applications, minimizing ethical controversies through a tone of inevitable and beneficial discovery.
Potential bioterrorism risks or religious objections to artificial life, present in other blocs, are not mentioned.
Continental Europe warns: SpudCell crosses a moral boundary, demanding urgent regulation to prevent unpredictable consequences for nature and society.
It uses ethical alarm language and invokes regulatory authority to position the discovery as a threat to be controlled, not a triumph.
Immediate medical benefits and international scientific consensus, highlighted in the Atlantic bloc, are not acknowledged.
India looks at SpudCell with practical interest: the technology must be adapted to local needs, with public investment and regulatory frameworks that protect national interests.
It adopts a measured, technical tone, shifting the debate from triumph or alarm to the issue of access and national control.
Ethical controversies raised by Europe and uncritical enthusiasm from the Atlantic are not addressed, focusing only on national utility.
Latin America denounces: SpudCell is a product of the Global North that risks perpetuating resource plunder and technological dependency, demanding a sovereign and solidarity-based response.
It frames the discovery within a narrative of historical injustice and power asymmetry, using emotional language to mobilize defense of regional interests.
Scientific details of the discovery and potential international collaborations, present in other blocs, are not mentioned.
Broaden your view
Zelensky Sacks Army Chief Syrskyi After Protests, Names Drapatyi Successor
9 languages · 28 outlets
From Economy & MarketsRecord US Student Loan Defaults Coincide with Fiscal Strain Across Latin America
3 languages · 7 outlets
From TechnologySamsung diversifies foldable line-up with three devices and higher prices ahead of Apple’s entry
10 languages · 34 outlets